Association of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors with cardiovascular events stratified by renal function: a network meta-analysis
Event:
ESC Congress 2019
Topic:
Diabetes and the Heart
Session:
Progress in secondary prevention - New treatments
